OCUL vs PGR · rev $63.7M vs P/E 10, rev $87.67B
Ocular Therapeutix Inc (OCUL) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
Latest reported PGR revenue for 2025-12-31 was $87.67B. Net income was $11.31B. Revenue was up 16.3% from 2024-12-31 to 2025-12-31. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
OCUL currently screens at market cap $1.76B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the OCUL and PGR stock pages for the full models.
Not investment advice.